The article shows for the first time that stem cell source, time to achieve full replacement of recipient cells with donor cells and graft-versus-host reactivity might contribute to HIV eradication. T...
Read moreA study shows that the CXCR4 chemokine receptors form aggregates in the cell membrane to be activated and carry out their function. This aggregation process is regulated by the presence of a ligand, b...
Read moreIP10 kinetics during the first week of TB treatment is associated with bacteriological confirmation at diagnosis in HIV-positive patients, according to a new study led by ISGlobal, an institution supp...
Read moreA simple blood test to determine levels of the IP-10 protein in blood could represent a key tool in the diagnosis of recently infected HIV individuals that have not yet developed virus-specific antibo...
Read morePeople living with HIV have a higher risk of developing tuberculosis (TB). In order to prevent TB in these patients, the WHO recommends a daily dose of isoniazid (6H) treatment during six months. Howe...
Read moreA clinical trial conducted by the IrsiCaixa AIDS Research Institute and the Fight AIDS Foundation has induced HIV control in 5 people who have been in an antiretroviral pause for 5, 13, 17, 20 and 27 ...
Read moreIn order to achieve this functional cure, the HIVACAR project proposes the administration of a combination of immunotherapy that includes therapeutic vaccines (one of them customized for each patient ...
Read moreA study led by Denise Naniche, ISGlobal researcher, in collaboration with researchers from Irsi-Caixa and the Manhiça Health Research Center (CISM), identifies a series of 4 biomarkers whose levels p...
Read moreA group of researchers at the Centre for Genomic Regulation (CRG) and the Pompeu Fabra University (UPF) in Barcelona, Spain, have developed a new technology that sheds light on the HIV infection and w...
Read moreA triple regimen based on an integrase inhibitor decreases viral load in semen very quickly, reducing transmission risk
Read moreIDIBELL Researchers write an editorial for the renowned journal The Lancet HIV discussing the potencial advantages of dual antiretroviral therapies
Read moreBSC has created an automatic platform, available for free via the web, on which researchers can enter a patient’s HIV-1 PR protease genomic sequence and predict the effectiveness of prescribing the ...
Read more